K. Wu, Y. Jiang, W. Zhou, B. Zhang, Y. Li, F. Xie, J. Zhang, X. Wang, M. Yan, Q. Xu, Z. Ren, W. Chen, and W. Cao, Long Noncoding RNA RC3H2 Facilitates Cell Proliferation and Invasion by Targeting MicroRNA-101-3p/EZH2 Axis in OSCC. Mol Ther Nucleic Acids 20 (2020) 97-110.
 N.K. Biswas, C. Das, S. Das, A. Maitra, S. Nair, T. Gupta, A.K. D'Cruz, R. Sarin, and P.P. Majumder, Lymph node metastasis in oral cancer is strongly associated with chromosomal instability and DNA repair defects. Int J Cancer 145 (2019) 2568-2579.
 W. He, H. Zhang, F. Han, X. Chen, R. Lin, W. Wang, H. Qiu, Z. Zhuang, Q. Liao, W. Zhang, Q. Cai, Y. Cui, W. Jiang, H. Wang, and Z. Ke, CD155T/TIGIT Signaling Regulates CD8(+) T-cell Metabolism and Promotes Tumor Progression in Human Gastric Cancer. Cancer Res 77 (2017) 6375-6388.
 E.D. Thompson, M. Zahurak, A. Murphy, T. Cornish, N. Cuka, E. Abdelfatah, S. Yang, M. Duncan, N. Ahuja, J.M. Taube, R.A. Anders, and R.J. Kelly, Patterns of PD-L1 expression and CD8 T cell infiltration in gastric adenocarcinomas and associated immune stroma. Gut 66 (2017) 794-801.
 Han, Xue, Chen, and Lieping, Anti-PD-1/PD-L1 therapy of human cancer: past, present, and future.
 H.B. Jie, R.M. Srivastava, A. Argiris, J.E. Bauman, L.P. Kane, and R.L. Ferris, Increased PD-1(+) and TIM-3(+) TILs during Cetuximab Therapy Inversely Correlate with Response in Head and Neck Cancer Patients. Cancer immunology research 5 (2017) 408-416.
 K.A. Frauwirth, J.L. Riley, M.H. Harris, R.V. Parry, J.C. Rathmell, D.R. Plas, R.L. Elstrom, C.H. June, and C.B. Thompson, The CD28 signaling pathway regulates glucose metabolism. Immunity 16 (2002) 769-77.
 R.V. Parry, J.M. Chemnitz, K.A. Frauwirth, A.R. Lanfranco, I. Braunstein, S.V. Kobayashi, P.S. Linsley, C.B. Thompson, and J.L. Riley, CTLA-4 and PD-1 receptors inhibit T-cell activation by distinct mechanisms. Molecular and cellular biology 25 (2005) 9543-53.
 V.A. Gerriets, and J.C. Rathmell, Metabolic pathways in T cell fate and function. Trends in immunology 33 (2012) 168-73.
 N.J. Maciver, S.R. Jacobs, H.L. Wieman, J.A. Wofford, J.L. Coloff, and J.C.J.J.o.L.B. Rathmell, Glucose metabolism in lymphocytes is a regulated process with significant effects on immune cell function and survival. 84 (2008).
 I. Atreya, C.C. Schimanski, C. Becker, S. Wirtz, H. Dornhoff, E. Schnurer, M.R. Berger, P.R. Galle, W. Herr, and M.F. Neurath, The T-box transcription factor eomesodermin controls CD8 T cell activity and lymph node metastasis in human colorectal cancer. Gut 56 (2007) 1572-8.
 J.P. Sleeman, The lymph node pre-metastatic niche. J Mol Med (Berl) 93 (2015) 1173-84.
 M. Broggi, M. Schmaler, N. Lagarde, and S.W.J.J.V.E. Rossi, Isolation of murine lymph node stromal cells. (2014).
 N. Eckert, M. Permanyer, K. Yu, K. Werth, and R. Förster, Chemokines and other mediators in the development and functional organization of lymph nodes. Immunological reviews 289 (2019) 62-83.
 G. Gasteiger, M. Ataide, and W. Kastenmüller, Lymph node - an organ for T-cell activation and pathogen defense. Immunological reviews 271 (2016) 200-20.
 C. Sun, R. Mezzadra, and T.N. Schumacher, Regulation and Function of the PD-L1 Checkpoint. Immunity 48 (2018) 434-452.
 C.S. Palmer, M. Ostrowski, B. Balderson, N. Christian, and S.M. Crowe, Glucose metabolism regulates T cell activation, differentiation, and functions. Frontiers in immunology 6 (2015) 1.
 D.E. Speiser, P.C. Ho, and G.J.N.R.I. Verdeil, Regulatory circuits of T cell function in cancer. (2016).
 J. Borst, T. Ahrends, N. Bąbała, C.J.M. Melief, and W. Kastenmüller, CD4(+) T cell help in cancer immunology and immunotherapy. Nature reviews. Immunology 18 (2018) 635-647.
 W.Y. Ho, C. Yee, and P.D. Greenberg, Adoptive therapy with CD8(+) T cells: it may get by with a little help from its friends. The Journal of clinical investigation 110 (2002) 1415-7.
 M.C. Chang, C.P. Chiang, C.L. Lin, J.J. Lee, L.J. Hahn, and J.H. Jeng, Cell-mediated immunity and head and neck cancer: with special emphasis on betel quid chewing habit. Oral Oncol 41 (2005) 757-75.
 J. Crespo, H. Sun, T.H. Welling, Z. Tian, and W.J.C.O.i.I. Zou, T cell anergy, exhaustion, senescence, and stemness in the tumor microenvironment. 25 (2013) 214-221.
 M. Brown, F.P. Assen, A. Leithner, J. Abe, H. Schachner, G. Asfour, Z. Bago-Horvath, J.V. Stein, P. Uhrin, and M.J.S. Sixt, Lymph node blood vessels provide exit routes for metastatic tumor cell dissemination in mice. 359 (2018) 1408-1411.
 D.S. Shin, and A.J.C.O.i.I. Ribas, The evolution of checkpoint blockade as a cancer therapy: what's here, what's next? 33 (2015) 23-35.
 R. Karim, E.S. Jordanova, S.J. Piersma, G.G. Kenter, L. Chen, J.M. Boer, C.J. Melief, and S.H. van der Burg, Tumor-expressed B7-H1 and B7-DC in relation to PD-1+ T-cell infiltration and survival of patients with cervical carcinoma. Clin Cancer Res 15 (2009) 6341-7.
 A.K. Mattox, J. Lee, W.H. Westra, R.H. Pierce, R. Ghossein, W.C. Faquin, T.J. Diefenbach, L.G. Morris, D.T. Lin, L.J. Wirth, A. Lefranc-Torres, E. Ishida, P.D. Chakravarty, L. Johnson, Y.C. Zeng, H. Chen, M.C. Poznansky, N.M. Iyengar, and S.I. Pai, PD-1 Expression in Head and Neck Squamous Cell Carcinomas Derives Primarily from Functionally Anergic CD4(+) TILs in the Presence of PD-L1(+) TAMs. Cancer Res 77 (2017) 6365-6374.
 A.M. Seifert, A. Eymer, M. Heiduk, R. Wehner, and L.J.C. Seifert, PD-1 Expression by Lymph Node and Intratumoral Regulatory T Cells Is Associated with Lymph Node Metastasis in Pancreatic Cancer. 12 2756.
 H. Terada, Y. Shimode, M. Furukawa, Y. Sato, and N.J.M. Hanai, The Utility of Ultrasonography in the Diagnosis of Cervical Lymph Nodes after Chemoradiotherapy for Head and Neck Squamous Cell Carcinoma. 57 (2021).
 M. Magnano, M. Bussi, A.D. Stefani, F. Milan, W. Lerda, V. Ferrero, F. Gervasio, R. Ragona, P. Gabriele, and G.J.A.o.-l. Valente, Prognostic factors for head and neck tumor recurrence. 115 (1995) 833-8.
 X. Ren, H. Wu, J. Lu, Y. Zhang, Z.J.C.B. Liang, and Therapy, PD1 protein expression in tumor infiltrated lymphocytes rather than PDL1 in tumor cells predicts survival in triple-negative breast cancer. 19 (2018) 00-00.
 D. O'Sullivan, D.E. Sanin, E.J. Pearce, and E.L.J.N.R.I. Pearce, Metabolic interventions in the immune response to cancer. 19 (2019) 1.
 Increased Tumor Glycolysis Characterizes Immune Resistance to Adoptive T Cell Therapy %J Cell Metabolism. (2018) S1550413118301785.
 B. Bengsch, A.L. Johnson, M. Kurachi, P.M. Odorizzi, K.E. Pauken, J. Attanasio, E. Stelekati, L.M. McLane, M.A. Paley, G.M. Delgoffe, and E.J. Wherry, Bioenergetic Insufficiencies Due to Metabolic Alterations Regulated by the Inhibitory Receptor PD-1 Are an Early Driver of CD8(+) T Cell Exhaustion. Immunity 45 (2016) 358-73.
 K. Renner, C. Bruss, A. Schnell, G. Koehl, and M.J.C.R. Kreutz, Restricting Glycolysis Preserves T Cell Effector Functions and Augments Checkpoint Therapy. 29 (2019) 135-150.e9.